Technology
Health
Medical

Valeritas

$0.3305
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0003 (0.09%) Today
+$0.0003 (0.09%) Today

Why Robinhood?

You can buy or sell Valeritas and other stocks, options, ETFs, and crypto commission-free!

About

Valeritas Holdings, Inc. Common Stock, also called Valeritas, is a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with diabetes. Read More It offers products under the V-Go brand. V-Go Disposable Insulin Delivery Device, is used by patients with type 2 diabetes to maintain target blood glucose goals. The firm's single-use disposable V-Go device includes V-Go PreFill and V-Go Link. The company was founded by Leisa Swanson and Robert R. Gonnelli on May 9, 2014 and is headquartered in Bridgewater, NJ.

Employees
125
Headquarters
Bridgewater, New Jersey
Founded
2014
Market Cap
33.00M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.18M
High Today
$0.35
Low Today
$0.32
Open Price
$0.35
Volume
249.04K
52 Week High
$4.58
52 Week Low
$0.30

Collections

Technology
Health
Medical
2017 IPO
US
North America

News

Seeking AlphaMar 6

Valeritas Holdings, Inc. 2018 Q4 - Results - Earnings Call Slides

The following slide deck was published by Valeritas Holdings, Inc. in conjunction with their 2018 Q4 earnings call. 1 21 Click to enlarge Notes:...

929
Seeking AlphaMar 5

Valeritas Holdings, Inc. (VLRX) CEO John Timberlake on Q4 2018 Results - Earnings Call Transcript

Valeritas Holdings, Inc. (NASDAQ:VLRX) Q4 2018 Results Conference Call March 4, 2019 4:30 PM ET Company Participants Greg Chodaczek - Gilmartin Group John Timberlake - President and Chief Executive Officer Erick Lucera - Chief Financial Officer Conference Call Participants Steven Lichtman - Oppenheimer Marie Thibault - BTIG Operator Welcome to Valeritas Fourth Quarter Financial Results Conference Call [Operator Instructions]. As a reminder, this conference call is being recorded today March 5, 201...

505
Seeking AlphaMar 5

Valeritas down 18% after hours on soft guidance

Valeritas Holdings (NASDAQ:VLRX) is down 18% after hours in response to its Q4 and 2018 results with an outlook that appears to have disappointed investors.

692

Earnings

-$1.87
-$1.30
-$0.73
-$0.16
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 9, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.